A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
McLachlan
C S
CS
Zhang
Zhiyong
Z
Mossop
Peter
P
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D018450:Disease Progression; D004336:Drug Antagonism; D004347:Drug Interactions; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D032383:Myocytes, Cardiac / Q000187:drug effects* / Q000378:metabolism; D020097:Natriuretic Peptide, Brain / Q000096:biosynthesis* / Q000097:blood; D010446:Peptide Fragments / Q000096:biosynthesis* / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D001241:Aspirin